Our findings open up new avenues for the use of miR-224-3p and FIP200 as novel biomarkers or molecular targets in the development of diagnostic and therapeutic strategies for hrHPV-induced cervical cancer. This evidence concerns the gene RB1CC1 and cervical cancer.